BIOREM Inc.
BIRMF
$1.49
$0.04363.01%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 27.68M | 26.20M | 27.29M | 29.61M | 22.80M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 27.68M | 26.20M | 27.29M | 29.61M | 22.80M |
| Cost of Revenue | 20.24M | 19.39M | 19.94M | 20.16M | 15.88M |
| Gross Profit | 7.44M | 6.81M | 7.35M | 9.45M | 6.92M |
| SG&A Expenses | 4.16M | 3.92M | 4.10M | 4.17M | 3.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -32.60K | -32.60K | -32.60K | -3.10K | -- |
| Total Operating Expenses | 24.40M | 23.31M | 24.04M | 24.37M | 19.23M |
| Operating Income | 3.28M | 2.89M | 3.25M | 5.24M | 3.58M |
| Income Before Tax | 3.13M | 2.73M | 3.04M | 5.07M | 3.39M |
| Income Tax Expenses | 832.10K | 727.50K | 807.90K | 1.25M | 801.60K |
| Earnings from Continuing Operations | 2.29 | 2.00 | 2.23 | 3.82 | 2.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.29M | 2.00M | 2.23M | 3.82M | 2.59M |
| EBIT | 3.28M | 2.89M | 3.25M | 5.24M | 3.58M |
| EBITDA | 3.64M | 3.22M | 3.55M | 5.49M | 3.73M |
| EPS Basic | 0.14 | 0.13 | 0.14 | 0.24 | 0.16 |
| Normalized Basic EPS | 0.12 | 0.11 | 0.12 | 0.20 | 0.13 |
| EPS Diluted | 0.10 | 0.08 | 0.10 | 0.21 | 0.15 |
| Normalized Diluted EPS | 0.11 | 0.09 | 0.10 | 0.18 | 0.12 |
| Average Basic Shares Outstanding | 66.07M | 65.74M | 62.80M | 62.90M | 62.80M |
| Average Diluted Shares Outstanding | 71.49M | 71.41M | 70.94M | 72.16M | 71.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |